Andreas Scheuba

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Metastatic Pheochromocytoma/Paraganglioma: Diagnostic Performance of Functional Imaging (18F-Fluoro-L-DOPA-, 68Ga-DOTA- and 18F-Fluoro-Deoxyglucose-Based PET/CT) and of 123I-MIBG Scintigraphy in 57 Patients and 527 Controls During Long-Term Follow-Up.

Metastatic Pheochromocytoma/Paraganglioma: Diagnostic Performance of Functional Imaging (18F-Fluoro-L-DOPA-, 68Ga-DOTA- and 18F-Fluoro-Deoxyglucose-Based PET/CT) and of 123I-MIBG Scintigraphy in 57 Patients and 527 Controls During Long-Term Follow-Up.

Journal: Cancers

Published: November 11, 2025

MetAAA Trial Patients Receiving Metformin Therapy Show Limited Improvement in Quality of Life Compared to AAA Patients with Placebo Intake-A Double-Blind, Randomized, and Placebo-Controlled Trial.

MetAAA Trial Patients Receiving Metformin Therapy Show Limited Improvement in Quality of Life Compared to AAA Patients with Placebo Intake-A Double-Blind, Randomized, and Placebo-Controlled Trial.

Journal: Medical sciences (Basel, Switzerland)

Published: October 06, 2025

Locally advanced pheochromocytoma/paraganglioma exhibit high metastatic recurrence and disease specific mortality rates: long-term follow-up of 283 patients.

Locally advanced pheochromocytoma/paraganglioma exhibit high metastatic recurrence and disease specific mortality rates: long-term follow-up of 283 patients.

Journal: European journal of endocrinology

Published: February 12, 2025

Editor's Choice - Metformin to Inhibit Progression of Abdominal Aortic Aneurysm: A Randomised, Placebo Controlled Clinical Trial.

Editor's Choice - Metformin to Inhibit Progression of Abdominal Aortic Aneurysm: A Randomised, Placebo Controlled Clinical Trial.

Journal: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery

Published: October 31, 2024

Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients.

Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients.

Journal: Frontiers in endocrinology

Published: April 17, 2024

Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge.

Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge.

Journal: Thrombosis research

Published: September 15, 2023

Comparing maximum diameter and volume when assessing the growth of small abdominal aortic aneurysms using longitudinal CTA data: cohort study.

Comparing maximum diameter and volume when assessing the growth of small abdominal aortic aneurysms using longitudinal CTA data: cohort study.

Journal: International journal of surgery (London, England)

Published: December 23, 2022

MetAAA trial patients show superior quality of life compared to patients under regular surveillance for small AAA: a single-center retrospective cohort study.

MetAAA trial patients show superior quality of life compared to patients under regular surveillance for small AAA: a single-center retrospective cohort study.

Journal: International journal of surgery (London, England)

Published: November 30, 2022

Growth prediction model for abdominal aortic aneurysms.

Growth prediction model for abdominal aortic aneurysms.

Journal: The British journal of surgery

Published: June 18, 2021

Histone citrullination as a novel biomarker and target to inhibit progression of abdominal aortic aneurysms.

Histone citrullination as a novel biomarker and target to inhibit progression of abdominal aortic aneurysms.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: November 29, 2020

Complement Factor C5a Is Increased in Blood of Patients with Abdominal Aortic Aneurysm and Has Prognostic Potential for Aneurysm Growth.

Complement Factor C5a Is Increased in Blood of Patients with Abdominal Aortic Aneurysm and Has Prognostic Potential for Aneurysm Growth.

Journal: Journal of cardiovascular translational research

Published: August 05, 2020

Polymorphisms in the IL-6 and TNF-α gene are associated with an increased risk of abdominal aortic aneurysm.

Polymorphisms in the IL-6 and TNF-α gene are associated with an increased risk of abdominal aortic aneurysm.

Journal: International journal of cardiology

Published: July 07, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026